SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 10/20/17 Angiodynamics Inc 8-K:5 10/17/17 1:31K Cadwalader Wickersh… LLP |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 21K
Delaware
|
11-3146460
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File
Number)
|
(IRS Employer
Identification No.)
|
(Address of Principal Executive Offices) (Zip Code)
|
(518) 795-1400
|
(Registrant’s telephone number, including area code)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
|
(a)
|
The Annual Meeting of Shareholders of AngioDynamics, Inc. (“AngioDynamics”) was held on October 17, 2017.
|
(b)
|
Shareholders voted on the matters set forth below.
|
1.
|
The nominees for election to the Board of Directors were elected, each as a Class II director to serve until the 2020 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, based upon the following votes:
|
Nominee
|
Votes For
|
Withheld
|
Broker Non Votes
|
|
Eileen O. Auen
|
30,581,280
|
492,986
|
2,217,882
|
|
James C. Clemmer
|
30,500,873
|
573,393
|
2,217,882
|
|
Howard W. Donnelly
|
30,451,097
|
623,169
|
2,217,882
|
|
Jan Stern Reed
|
30,581,348
|
492,918
|
2,217,882
|
2.
|
The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics’ independent registered public accounting firm for the fiscal year ending May 31, 2018 was approved based upon the following votes:
|
Votes for approval
|
33,069,290
|
|
Votes against
|
29,597
|
|
Abstentions
|
193,261
|
|
There were no broker non-votes for this item. |
3.
|
The proposal to approve, on an advisory basis, AngioDynamics’ executive compensation of its named executive officers was approved based upon the following votes:
|
Votes for approval
|
30,253,432
|
|
Votes against
|
720,710
|
|
Abstentions
|
100,124
|
|
Broker non vtes
|
2,217,882
|
4.
|
The proposal on the frequency of future advisory votes on executive compensation received the following votes:
|
For 3 Years
|
7,156,014
|
|
For 2 Years
|
14,153
|
|
For 1 Year
|
23,804,430
|
|
Abstentions
|
99,669
|
|
Broker-Non Votes
|
2,217,882
|
|
See Item 5.07(d) below.
|
(c)
|
Not applicable.
|
(d)
|
Based upon the results set forth in item (b) (4) above, the Board of Directors has determined that advisory votes on executive compensation will be submitted to shareholders on an annual basis.
|
ANGIODYNAMICS, INC.
(Registrant)
|
|||
Date: October 20, 2017
|
By:
|
/s/ Stephen A. Trowbridge | |
Stephen A. Trowbridge | |||
Senior Vice President and | |||
General Counsel |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
5/31/18 | ||||
Filed on: | 10/20/17 | |||
For Period End: | 10/17/17 | DEF 14A | ||
List all Filings |